From Taboo Topic to Mainstream Women’s Health Monitoring
Hormone-tracking wearables are digital devices and apps that monitor biological signals linked to estrogen, progesterone and related hormones over time, turning invisible cycle and menopause changes into trackable, personalized health data women can use to understand symptoms and guide care conversations. This shift sits on top of a long education gap. Only half of women were taught about periods before their first one, and 96 percent could not identify basic menstrual phases. Many arrive at the doctor without language for their own cycles, and 68 percent report they do not trust their OB-GYN. As a result, care tends to be reactive instead of preventative. Fitness brands, consumer tech companies and reproductive health technology startups are stepping in, reframing women’s health as an ongoing, measurable process rather than an occasional appointment or a private problem to endure alone.
Fitness Platforms and Menopause Tracking Devices Gain Ground
Women’s health innovation has moved from niche sidelines into the center of the consumer wellness market. Fitness platforms are pairing structured programs with data to show how movement affects hormonal life stages. In a 60-day study of Peloton members aged 40 to 65, 84 percent reported overall improvement in menopause symptoms, with fatigue, brain fog and memory issues improving by 26 to 41 percent on average. Pvolve’s Menopause Strong Plan, built with clinical input, focuses on strength, mobility, functional cardio and pelvic floor work to counter age-related muscle loss that accelerates during menopause. Alongside programs, menopause tracking devices and hormone-aware wearables help women correlate symptoms with sleep, stress and activity patterns. These tools are turning exercise and recovery into measurable levers for symptom relief, making women’s health monitoring part of daily routines instead of an occasional check-up.
Hormone-Tracking Wearables Move From Tracking to Interpretation
The new wave of hormone-tracking wearables aims to interpret data, not only log it. Oura is building women’s health models that combine sleep, stress, activity and cycle information so insights align with real hormonal phases instead of generic averages. Whoop has added a women’s health biomarker panel with 11 female-specific markers and reports that women are one of its fastest-growing segments, with 150 percent year-over-year growth. Integrations are emerging too: Mira links lab-grade hormone testing with Oura’s continuous data, connecting fertility and cycle patterns with daily readiness and recovery scores. Meanwhile, Maven Clinic is embedding AI into fertility, pregnancy, postpartum and menopause care, drawing on more than a billion data points to tailor support. Together, these reproductive health technology platforms are building a feedback loop in which wearable data informs care, and care in turn refines what the devices track.
New Sensors Target the Hormonal Blind Spots
Even with smarter models, many devices still assume regular 28-day cycles and overlook conditions like PCOS or endometriosis. New hormone tracking wearables are trying to close that blind spot. Clair, built by Stanford graduates, describes itself as the first non-invasive continuous hormone tracker, using a 10-biosensor stack and 500 biomarkers to follow estrogen, progesterone, LH and FSH in real time. Its models are trained specifically on female biology, including irregular cycles and anovulation. Eli Health takes a complementary path with its saliva-based Hormometer, which tracks free cortisol, progesterone and testosterone at home. Because free cortisol better reflects sleep disruption, mood swings and fatigue, it can help women match subjective symptoms to objective hormonal changes. These tools challenge the long-standing single blood draw or calendar-prediction model by acknowledging that hormones fluctuate constantly and need continuous, context-aware measurement.
Empowerment, But Data Gaps and Clarity Challenges Remain
Hormone-aware wearables are giving women a new kind of power: the ability to arrive at appointments with trend lines, symptom logs and clear questions. Oura’s women’s health tools are designed to be non-dismissive, helping users recognize patterns across the full reproductive spectrum, from early cycles through menopause, so clinical conversations start further ahead. Yet structural gaps remain. Fewer than one-third of OB-GYNs are trained in menopause care, and many AI tools still fail to give adequate answers to women’s health queries. The supplement market has expanded rapidly, with roughly 4,000 women’s health products competing for attention, often marketed as universal fixes despite complex hormonal needs. Wearables and digital platforms can reduce uncertainty and build confidence, but they work best when paired with clear education and responsive clinicians who are prepared to interpret the data alongside women, not instead of them.
